Third, lung cancers harboring minor EGFR mutations, which are considered to be refractory to EGFR - TKI, were included in Mt, whereas lung cancers harboring anaplastic lymphoma kinase genes or ROS-1 gene mutations were included in Wt. The gene discussed is EGFR; the disease is lung carcinoma.